• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    7/10/23 1:50:32 PM ET
    $STRC
    $TCBP
    $TEAF
    $TGL
    Wholesale Distributors
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $STRC alert in real time by email

     

    On Monday, 65 companies hit new 52-week lows.

    Things to Consider About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE).
    • The smallest company in terms of market cap to set a new 52-week low was Biodexa Pharmaceuticals (NASDAQ:BDRX).
    • Tivic Health Systems (NASDAQ:TIVC) shares traded down 40.69% to reach its 52-week low, making it the biggest loser.
    • Chijet Motor Co (NASDAQ:CJET) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    Stocks dropping to new 52-week lows on Monday:

    • Bristol-Myers Squibb (NYSE:BMY) shares fell to $62.30 on Monday, setting a new 52-week low with a shift of down 0.54%.
    • Humana (NYSE:HUM) shares reached a new 52-week low of $427.21 on Monday morning, moving up 0.06%.
    • Amcor (NYSE:AMCR) stock hit a new 52-week low of $9.48. The stock was down 3.77% on the session.
    • FMC (NYSE:FMC) stock hit $88.80 on Monday morning, setting a new 52-week low for a change of down 14.62%.
    • KT (NYSE:KT) shares fell to $11.10 on Monday, setting a new 52-week low with a shift of up 0.04%.
    • UGI (NYSE:UGI) shares were down 0.81% for the day, having made a 52-week low of $25.69.
    • Clearway Energy (NYSE:CWEN) shares moved down 0.29% on Monday to hit a new 52-week low of $27.38, drifting down 0.29%.
    • California Water Servs Gr (NYSE:CWT) shares set a new yearly low of $49.27 this morning. The stock was down 0.37% on the session.
    • SunPower (NASDAQ:SPWR) stock hit a new 52-week low of $8.99. The stock was up 1.49% on the session.
    • Northwest Natural Hldg (NYSE:NWN) shares reached a new 52-week low of $41.64 on Monday morning, moving up 0.12%.
    • Duckhorn Portfolio (NYSE:NAPA) stock broke to a new 52-week low of $12.54 on Monday. Shares of the company traded down 1.41%.
    • Kenon Hldgs (NYSE:KEN) stock achieved a new 52-week low on Monday morning, hitting $22.85 and moving down 2.52%.
    • Enanta Pharma (NASDAQ:ENTA) shares were up 1.69% for the day, having made a 52-week low of $19.29.
    • Chijet Motor Co (NASDAQ:CJET) stock achieved a new 52-week low on Monday morning, hitting $2.31 and moving 0.0% (flat).
    • First Foundation (NASDAQ:FFWM) shares made a new 52-week low of $3.75 on Monday. The stock was down 0.52% for the day.
    • Douglas Elliman (NYSE:DOUG) shares were up 5.6% for the day, having made a 52-week low of $2.07.
    • Tortoise Essential Assets (NYSE:TEAF) shares moved down 0.32% on Monday to hit a new 52-week low of $12.20, drifting down 0.32%.
    • Delaware Inv Natl Muni (AMEX:VFL) shares fell to $9.85 on Monday, setting a new 52-week low with a shift of down 0.2%.
    • OptiNose (NASDAQ:OPTN) stock hit $1.05 on Monday morning, setting a new 52-week low for a change of down 4.02%.
    • Cherry Hill Mortgage (NYSE:CHMI) shares fell to $4.33 on Monday, setting a new 52-week low with a shift of down 0.23%.
    • Meihua Intl Medical Techs (NASDAQ:MHUA) shares moved up 1.24% on Monday to hit a new 52-week low of $2.38, drifting up 1.24%.
    • Jerash Holdings (US) (NASDAQ:JRSH) stock dropped to a yearly low on Monday of $3.64. Shares traded down 1.35%.
    • 22nd Century Group (NASDAQ:XXII) shares hit a yearly low of $2.42. The stock was down 7.47% on the session.
    • Interactive Strength (NASDAQ:TRNR) shares fell to $2.49 on Monday, setting a new 52-week low with a shift of up 3.44%.
    • Sarcos Technology (NASDAQ:STRC) stock hit $1.46 on Monday morning, setting a new 52-week low for a change of down 6.23%.
    • Yunji (NASDAQ:YJ) stock hit a new 52-week low of $1.27. The stock was down 7.64% on the session.
    • Psychemedics (NASDAQ:PMD) shares set a new 52-week low of $4.19. The stock traded up 0.46%.
    • Tattooed Chef (NASDAQ:TTCF) shares reached a new 52-week low of $0.21 on Monday morning, moving down 11.54%.
    • Powerbridge Technologies (NASDAQ:PBTS) stock hit $0.61 on Monday morning, setting a new 52-week low for a change of down 2.25%.
    • Cineverse (NASDAQ:CNVS) stock hit a yearly low of $1.53. The stock was down 3.4% for the day.
    • Treasure Global (NASDAQ:TGL) shares fell to $0.90 on Monday, setting a new 52-week low with a shift of down 3.29%.
    • Avalon Globocare (NASDAQ:ALBT) stock set a new 52-week low of $1.19 on Monday, moving up 6.19%.
    • ABVC BioPharma (NASDAQ:ABVC) shares set a new 52-week low of $0.44. The stock traded down 2.06%.
    • FOXO Technologies (AMEX:FOXO) shares moved down 7.27% on Monday to hit a new 52-week low of $0.18, drifting down 7.27%.
    • Greenwave Tech Solns (NASDAQ:GWAV) stock dropped to a yearly low on Monday of $0.70. Shares traded down 3.1%.
    • T Stamp (NASDAQ:IDAI) shares were down 5.37% for the day, having made a 52-week low of $0.96.
    • iSun (NASDAQ:ISUN) shares set a new 52-week low of $0.37. The stock traded down 1.19%.
    • Ault Alliance (AMEX:AULT) shares fell to $4.86 on Monday, setting a new 52-week low with a shift of down 1.78%.
    • Enservco (AMEX:ENSV) stock broke to a new 52-week low of $0.29 on Monday. Shares of the company traded up 2.07%.
    • OceanPal (NASDAQ:OP) stock broke to a new 52-week low of $1.26 on Monday. Shares of the company traded down 7.56%.
    • SuperCom (NASDAQ:SPCB) shares made a new 52-week low of $0.92 on Monday. The stock was up 0.36% for the day.
    • Ra Medical Systems (AMEX:RMED) shares set a new 52-week low of $0.70. The stock traded down 5.47%.
    • Gaucho Group Holdings (NASDAQ:VINO) shares moved up 1.99% on Monday to hit a new 52-week low of $0.50, drifting up 1.99%.
    • Blue Star Foods (NASDAQ:BSFC) stock hit a new 52-week low of $1.05. The stock was down 5.65% on the session.
    • Ucommune International (NASDAQ:UK) shares made a new 52-week low of $0.50 on Monday. The stock was up 1.63% for the day.
    • G Medical Innovations (NASDAQ:GMVD) shares made a new 52-week low of $0.32 on Monday. The stock was up 1.73% for the day.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new 52-week low of $0.43. The stock traded down 1.97%.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares were down 2.76% for the day, having made a 52-week low of $3.76.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $STRC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STRC
    $TCBP
    $TEAF
    $TGL

    CompanyDatePrice TargetRatingAnalyst
    Amcor plc
    $AMCR
    4/1/2026$50.00Buy
    Deutsche Bank
    Enanta Pharmaceuticals Inc.
    $ENTA
    3/26/2026$20.00Buy
    Rodman & Renshaw
    Amcor plc
    $AMCR
    3/20/2026$43.00Overweight → Equal Weight
    Wells Fargo
    Pfizer Inc.
    $PFE
    3/2/2026$35.00Hold → Buy
    Argus
    Pfizer Inc.
    $PFE
    2/25/2026$25.00Underperform
    RBC Capital Mkts
    Bristol-Myers Squibb Company
    $BMY
    2/25/2026$60.00Sector Perform
    RBC Capital Mkts
    Pfizer Inc.
    $PFE
    2/20/2026$25.00Underweight
    Barclays
    Bristol-Myers Squibb Company
    $BMY
    2/20/2026$75.00Overweight
    Barclays
    More analyst ratings

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Barry Michael F bought $249,938 worth of shares (18,072 units at $13.83), increasing direct ownership by 1,157% to 19,634 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    3/5/26 12:11:06 PM ET
    $FMC
    Major Chemicals
    Industrials

    President, CenterWell Shetty Sanjay K bought $150,016 worth of Humana Common (810 units at $185.21), increasing direct ownership by 7% to 11,657 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 11:48:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    Pres Tech/Chief Product Off Huidor Mark Antonio bought $75,000 worth of shares (37,500 units at $2.00), increasing direct ownership by 25% to 190,061 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:57:19 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ming Tracy

    4 - T Stamp Inc (0001718939) (Issuer)

    4/8/26 3:53:22 PM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Gowasack Andrew Carl

    4 - T Stamp Inc (0001718939) (Issuer)

    4/8/26 3:52:16 PM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Wilson Lance Robert

    4 - T Stamp Inc (0001718939) (Issuer)

    4/8/26 6:25:53 AM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    $STRC
    $TCBP
    $TEAF
    $TGL
    SEC Filings

    View All

    SEC Form DEFA14A filed by abrdn National Municipal Income Fund

    DEFA14A - abrdn National Municipal Income Fund (0000895574) (Filer)

    4/8/26 7:01:42 PM ET
    $VFL
    Finance/Investors Services
    Finance

    SEC Form S-1 filed by Avalon GloboCare Corp.

    S-1 - Avalon GloboCare Corp. (0001630212) (Filer)

    4/8/26 5:19:26 PM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form RW filed by Avalon GloboCare Corp.

    RW - Avalon GloboCare Corp. (0001630212) (Filer)

    4/8/26 5:04:55 PM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Deutsche Bank initiated coverage on Amcor with a new price target

    Deutsche Bank initiated coverage of Amcor with a rating of Buy and set a new price target of $50.00

    4/1/26 8:21:16 AM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Rodman & Renshaw initiated coverage on Enanta Pharmaceuticals with a new price target

    Rodman & Renshaw initiated coverage of Enanta Pharmaceuticals with a rating of Buy and set a new price target of $20.00

    3/26/26 8:54:41 AM ET
    $ENTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amcor downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Amcor from Overweight to Equal Weight and set a new price target of $43.00

    3/20/26 8:33:49 AM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $STRC
    $TCBP
    $TEAF
    $TGL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 11, 2024 - FDA Approves New Treatment for Hemophilia A or B

    For Immediate Release: October 11, 2024 Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors (neutralizing antibodies). “Today’s approval of Hympavzi pro

    10/11/24 2:12:15 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

    Pfizer Inc. (NYSE:PFE) announced today that its shareholders and the general public are invited to access its virtual 2026 Annual Meeting of Shareholders on Thursday, April 23, 2026, at 9:00 a.m. EDT. Shareholders can find information on accessing and registering for the virtual meeting at https://meetnow.global/PFE2026. On the day of the Annual Meeting, shareholders may begin logging into the virtual meeting platform at 8:45 a.m. EDT using either the control number found on their proxy card, voting instruction form or the notice that was previously received. Only shareholders who log into the meeting using a control number will have the ability to ask questions or vote during the live me

    4/9/26 10:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours

    Collaboration leverages OBT's proprietary OGAP®-Verify discovery platform and drug development capabilities in alignment with BMS's expertise to advance selected novel oncology targets This is OBT's third major pharma collaboration within the past 12 months and reflects strong validation of the OGAP®-Verify platform's potential to drive oncology innovationOBT to receive an upfront payment and may be eligible to receive milestone payments, as well as royalties on net sales Oxford, UK and San Jose, California, 9 April 2026 – Oxford BioTherapeutics ("OBT"), is a clinical stage oncology company focused on the discovery and development of immuno-oncology (IO) and Antibody Drug Conjugate (ADC)-b

    4/9/26 7:00:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Humana Goes Live with b.well to Deliver on Health Data Interoperability Commitments

    Humana and b.well are delivering on a shared commitment to improve individual access to health data and reduce administrative waste in the healthcare system. Humana Inc. announced today it has gone live with b.well Connected Health, fulfilling a shared commitment to simplifying how individuals access, understand, and use their health data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260409894576/en/ Through the relationship, Humana will leverage b.well's national health data network to enable individuals to securely connect and access their health data across multiple providers, health plans, pharmacies, and digital health

    4/9/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Leadership Updates

    Live Leadership Updates

    View All

    Douglas Elliman Names Areeje Akhtar Oriol Chief of Staff to President and CEO Michael S. Liebowitz

    Seasoned luxury strategy and growth executive brings deep experience in brand development, brokerage platform building and the ultra-high-net-worth market to Douglas Elliman leadership teamNEW YORK, April 8, 2026 /PRNewswire/ -- Douglas Elliman Real Estate, the preeminent luxury residential real estate brokerage in the United States, today announced the appointment of Areeje Akhtar Oriol as Chief of Staff to President and Chief Executive Officer Michael S. Liebowitz. In this role, Oriol will work directly with Liebowitz and the firm's senior leadership team on strategic initiatives, organizational alignment and the continued evolution of the platform supporting Elliman's agents and clients w

    4/8/26 11:28:00 AM ET
    $DOUG
    Real Estate
    Finance

    Preliminary Results for the Year Ended 31 December 2025

    March 27, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company" or, together with its subsidiaries, the "Group") Preliminary Results for the Year Ended 31 December 2025 Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, announces its audited preliminary results for the year ended 31 December 2025. For more information, please contact: Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFOTel: +44 (0)29 2048 0180www.biodexapharma.com About Biodexa The Company's lead development programs include eRapa, under development for Familial Adenoma

    3/27/26 5:00:00 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    $STRC
    $TCBP
    $TEAF
    $TGL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Financials

    Live finance-specific insights

    View All

    UGI Corporation to Hold Fiscal 2026 Second Quarter Earnings Conference Call on Thursday, May 7

    UGI Corporation (NYSE: UGI) will announce its Fiscal 2026 second quarter results after the market closes on May 6, 2026. The company will hold a live audio webcast of its conference call to discuss these results at 9:00 AM ET on Thursday, May 7. Interested parties may listen to the webcast both live and in replay at https://www.ugicorp.com/investors/financial-reports/events-and-presentations or by visiting the company's website, https://www.ugicorp.com and clicking on "Investors" and then "Events and Presentations." About UGI UGI Corporation (NYSE:UGI) is a distributor and marketer of energy products and services in the U.S. and Europe. UGI offers safe, reliable, affordable, and sustain

    4/7/26 5:00:00 PM ET
    $UGI
    Natural Gas Distribution
    Utilities

    abrdn National Municipal Income Fund (VFL) Announces Adjournment of Special Shareholder Meeting Relating to Proposed Reorganization

    PHILADELPHIA, April 1, 2026 /PRNewswire/ -- abrdn National Municipal Income Fund (NYSE:VFL) announces that the Special Meeting of Shareholders was held and adjourned today, to allow for the solicitation of additional proxies to achieve the requisite quorum. The Fund has set a new adjournment date for its Special Meeting of Shareholders of Wednesday, April 15, 2026, at 11:00 am Eastern Time. Shareholders of the Fund are being asked to vote on the proposal to approve an Agreement and Plan of Reorganization between the abrdn National Municipal Income Fund (NYSE:VFL) and MFS Municip

    4/1/26 4:17:00 PM ET
    $MFM
    $VFL
    Finance Companies
    Finance
    Finance/Investors Services

    Fengate acquires interest in operational U.S. solar portfolio

    Houston, TX, March 31, 2026 (GLOBE NEWSWIRE) -- Fengate Asset Management (Fengate) is pleased to announce the acquisition of a 50% interest in a 227 MWac portfolio of 12 operating solar projects in the western United States. The investment is a 50/50 joint-venture with independent power producer, Clearway Energy Inc. (NYSE:CWEN), an existing investment partner of Fengate's on an operational wind facility. "This transaction supports our energy transition strategy to acquire core, operating long-term contracted renewable projects for Fengate Infrastructure Yield Fund, and we are proud to partner with Clearway on a second renewables investment," said Greg Calhoun, Managing Director an

    3/31/26 9:00:00 AM ET
    $CWEN
    Electric Utilities: Central
    Utilities